Agentes antineoplásicos - Suministro de medicamentos de uso humano que contiene los principios activos siguientes: Vemurafenib, Dornasa Alfa, Vismodegib, Cobime...
€37.4M
Award value
76% under estimate
Roche pharma, S.A.
1 contract won, worth €37.4M, from 1 public buyer.
Main sectors Medical equipment & pharmaceuticals 1
Follow this company
We email you when this company wins a new contract. Free, one click to stop.
Relations
Who this company works for
Shares of the one contract this company has won.
Register
Contracts won
Each bar compares an award with the largest on this page, €37.4M.